Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

JP1520 PIK3CA E545K HA Citations (2)

Originally described in: Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells.
Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS Cancer Res. 2005 Dec 1. 65(23):10992-1000. PubMed Journal

Articles Citing JP1520 PIK3CA E545K HA

Articles
Repression of cancer cell senescence by PKCiota. Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard MA, Parolin DA, Lavictoire SJ, Amin MS, Islam S, Lorimer IA. Oncogene. 2012 Aug 2;31(31):3584-96. doi: 10.1038/onc.2011.524. Epub 2011 Nov 28. PubMed
The adherens junction protein afadin is an AKT substrate that regulates breast cancer cell migration. Elloul S, Kedrin D, Knoblauch NW, Beck AH, Toker A. Mol Cancer Res. 2014 Mar;12(3):464-76. doi: 10.1158/1541-7786.MCR-13-0398. Epub 2013 Nov 22. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.